Molecular basis of the VHL hereditary cancer syndrome
The DOI matches its Crossref record; 145 of the 146 references it cites were found in a registry or an index.
Abstract
The von Hippel-Lindau hereditary cancer syndrome was first described about 100 years ago. The unusual clinical features of this disorder predicted a role for the von Hippel-Lindau gene (VHL) in the oxygen-sensing pathway. Indeed, recent studies of this gene have helped to decipher how cells sense changes in oxygen availability, and have revealed a previously unappreciated role of prolyl hydroxylation in intracellular signalling. These studies, in turn, are laying the foundation for the treatment of a diverse set of disorders, including cancer, myocardial infarction and stroke.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the PHDs utilize ␣-ketoglutarate as a cosubstrate and require ferrous iron (Fe 2ϩ ) and ascorbate as cofactors (Kaelin, 2002;Schofield and Zhang, 1999).”
From Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase (2005) · cites this paper as Kaelin, 2002
In the citing paper
“Since pVHL binding to the ODD domain is dependent on PHD activity (Kaelin, 2002;Safran and Kaelin, 2003)”
From Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase (2005) · cites this paper as Kaelin, 2002
Citations
Cites
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“The interaction of pVHL with HIF-α is governed by the enzymatic hydroxylation of conserved proline residues that are located within highly conserved, peptidic, pVHL-binding domains within the HIF-α subunit”
BackgroundEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914
Mutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Self-citationAsparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., & Linehan, W. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9700 · Cited by 1,529
Bai, C., Sen, P., Hofmann, K., Ma, L., Goebl, M., Harper, J. W., & Elledge, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80098-7 · Cited by 1,415
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
SCF and Cullin/RING H2-Based Ubiquitin Ligases
Deshaies, R. J. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.435 · Cited by 1,242
Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., & Ratcliffe, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8104 · Cited by 1,084
Cockman, M. E., Masson, N., Mole, D. R., Jaakkola, P., Chang, G.-W., Clifford, S. C., Maher, E. R., Pugh, C. W., Ratcliffe, P. J., & Maxwell, P. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002740200 · Cited by 1,050
Tanimoto, K., Makino, Y., Pereira, T., & Poellinger, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4298 · Cited by 928
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G., & Goldberg, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10595 · Cited by 892
Self-citationHypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.
Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M., & Johnson, R. S. (2000) · PubMed · Cited by 890
Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function
Stebbins, C. E., Kaelin, W. G., & Pavletich, N. P. (1999) · Science · doi:10.1126/science.284.5413.455 · Cited by 860
Self-citationHIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation
Yu, F., White, S. B., Zhao, Q., & Lee, F. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181341498 · Cited by 796
Rbx1, a Component of the VHL Tumor Suppressor Complex and SCF Ubiquitin Ligase
Kamura, T., Koepp, D. M., Conrad, M. N., Skowyra, D., Moreland, R. J., Iliopoulos, O., Lane, W. S., Kaelin, W. G., Elledge, S. J., Conaway, R. C., et al. (1999) · Science · doi:10.1126/science.284.5414.657 · Cited by 781
Self-citationStructure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling
Min, J.-H., Yang, H., Ivan, M., Gertler, F., Kaelin, W. G., & Pavletich, N. P. (2002) · Science · doi:10.1126/science.1073440 · Cited by 765
Self-citationInhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
Kondo, K., Klco, J., Nakamura, E., Lechpammer, M., & Kaelin, W. G. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00043-0 · Cited by 761
Self-citationE2F-1 Functions in Mice to Promote Apoptosis and Suppress Proliferation
Field, S. J., Tsai, F.-Y., Kuo, F., Zubiaga, A. M., Kaelin, W. G., Livingston, D. M., Orkin, S. H., & Greenberg, M. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81255-6 · Cited by 754
Self-citationStructural basis for the recognition of hydroxyproline in HIF-1α by pVHL
Hon, W.-C., Wilson, M. I., Harlos, K., Claridge, T. D. W., Schofield, C. J., Pugh, C. W., Maxwell, P. H., Ratcliffe, P. J., Stuart, D. I., & Jones, E. Y. (2002) · Nature · doi:10.1038/nature00767 · Cited by 751 · cited 1×
“The hydroxyl group mediates the pVHL–HIF-α interaction by participating in two essential hydrogen bonds with hydrophilic side chains that are located in the pVHL β-domai”
BackgroundHewitson, K. S., McNeill, L. A., Riordan, M. V., Tian, Y.-M., Bullock, A. N., Welford, R. W., Elkins, J. M., Oldham, N. J., Bhattacharya, S., Gleadle, J. M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200273200 · Cited by 719
Tumour suppression by the human von Hippel-Lindau gene product
Iliopoulos, O., Kibel, A., Gray, S., & Kaelin, W. G. (1995) · Nature Medicine · doi:10.1038/nm0895-822 · Cited by 703
Self-citationBinding of the von Hippel-Lindau Tumor Suppressor Protein to Elongin B and C
Kibel, A., Iliopoulos, O., DeCaprio, J. A., & Kaelin, W. G. (1995) · Science · doi:10.1126/science.7660130 · Cited by 671
Self-citationVon Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma
Seizinger, B. R., Rouleau, G. A., Ozelius, L. J., Lane, A. H., Farmer, G. E., Lamiell, J. M., Haines, J., Yuen, J. W. M., Collins, D., Majoor-Krakauer, D., et al. (1988) · Nature · doi:10.1038/332268a0 · Cited by 662
Kamura, T., Sato, S., Iwai, K., Czyzyk-Krzeska, M., Conaway, R. C., & Conaway, J. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190332597 · Cited by 653
Tian, H., Hammer, R. E., Matsumoto, A. M., Russell, D. W., & McKnight, S. L. (1998) · Genes & Development · doi:10.1101/gad.12.21.3320 · Cited by 647
Mechanism-Based Target Identification and Drug Discovery in Cancer Research
Gibbs, J. B. (2000) · Science · doi:10.1126/science.287.5460.1969 · Cited by 606
Inhibition of Transcription Elongation by the VHL Tumor Suppressor Protein
Duan, D. R., Pause, A., Burgess, W. H., Aso, T., Chen, D. Y. T., Garrett, K. P., Conaway, R. C., Conaway, J. W., Linehan, W. M., & Klausner, R. D. (1995) · Science · doi:10.1126/science.7660122 · Cited by 568
Chen, F., Kishida, T., Yao, M., Hustad, T., Glavac, D., Dean, M., Gnarra, J. R., Orcutt, M. L., Duh, F. M., Glenn, G., et al. (1995) · Human Mutation · doi:10.1002/humu.1380050109 · Cited by 556
Gnarra, J. R., Zhou, S., Merrill, M. J., Wagner, J. R., Krumm, A., Papavassiliou, E., Oldfield, E. H., Klausner, R. D., & Linehan, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10589 · Cited by 531
Maher, E. R., & Kaelin, W. G. (1997) · Medicine · doi:10.1097/00005792-199711000-00001 · Cited by 528
Self-citationIwai, K., Yamanaka, K., Kamura, T., Minato, N., Conaway, R. C., Conaway, J. W., Klausner, R. D., & Pause, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12436 · Cited by 508
Benjamin, L. E., & Keshet, E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8761 · Cited by 506
Zbar, B., Kishida, T., Chen, F., Schmidt, L., Maher, E. R., Richards, F. M., Crossey, P. A., Webster, A. R., Affara, N. A., Ferguson-Smith, M. A., et al. (1996) · Human Mutation · doi:10.1002/(sici)1098-1004(1996)8:4<348::aid-humu8>3.0.co;2-3 · Cited by 506
Pause, A., Lee, S., Worrell, R. A., Chen, D. Y. T., Burgess, W. H., Linehan, W. M., & Klausner, R. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2156 · Cited by 493
Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene
Stolle, C. A., Glenn, G. M., Zbar, B., Humphrey, J. S., Choyke, P. L., Walther, M. M., Pack, S., Hurley, K., Andrey, C., Klausner, R. D., et al. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)12:6<431::aid-humu10>3.0.co;2-y · Cited by 477
Ohh, M., Yauch, R. L., Lonergan, K. M., Whaley, J. M., Stemmer-Rachamimov, A. O., Louis, D. N., Gavin, B. J., Kley, N., Kaelin, W. G., & Iliopoulos, O. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80096-9 · Cited by 477
Self-citationShuin, T., Kondo, K., Torigoe, S., Kishida, T., Kubota, Y., Hosaka, M., Nagashima, Y., Kitamura, H., Latif, F., & Zbar, B. (1994) · PubMed · Cited by 471
Pheochromocytomas, Multiple Endocrine Neoplasia Type 2, and von Hippel-Lindau Disease
Neumann, H., Berger, D. P., Sigmund, G., Blum, U., Schmidt, D., Parmer, R. J., Volk, B., & Kirste, G. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311183292103 · Cited by 465
Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α
Freedman, S. J., Sun, Z.-Y. J., Poy, F., Kung, A. L., Livingston, D. M., Wagner, G., & Eck, M. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082117899 · Cited by 455
Maranchie, J. K., Vasselli, J. R., Riss, J., Bonifacino, J. S., Linehan, W. M., & Klausner, R. D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00044-2 · Cited by 432
Vascular tumors in livers with targeted inactivation of the von Hippel–Lindau tumor suppressor
Haase, V. H., Glickman, J. N., Socolovsky, M., & Jaenisch, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1583 · Cited by 424
Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes
Schofield, C. J., & Zhang, Z. (1999) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)00036-6 · Cited by 408
Structural basis for Hif-1α/CBP recognition in the cellular hypoxic response
Dames, S. A., Martinez-Yamout, M., De Guzman, R. N., Dyson, H. J., & Wright, P. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082121399 · Cited by 402
Dor, Y. (2002) · The EMBO Journal · doi:10.1093/emboj/21.8.1939 · Cited by 390
Hoffman, M. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1019 · Cited by 382
Lonergan, K. M., Iliopoulos, O., Ohh, M., Kamura, T., Conaway, R. C., Conaway, J. W., & Kaelin, W. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.732 · Cited by 381
Self-citationLisztwan, J., Imbert, G., Wirbelauer, C., Gstaiger, M., & Krek, W. (1999) · Genes & Development · doi:10.1101/gad.13.14.1822 · Cited by 379
Foster, K., Prowse, A., van den Berg, A., Fleming, S., Hulsbeek, M. M. F., Crossey, P. A., Richards, F. M., Cairns, P., Affara, N. A., Ferguson-Smith, M. A., et al. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.12.2169 · Cited by 373
Mukhopadhyay, D., Knebelmann, B., Cohen, H. T., Ananth, S., & Sukhatme, V. P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5629 · Cited by 341
Wizigmann-Voos, S., Breier, G., Risau, W., & Plate, K. H. (1995) · PubMed · Cited by 326
Drake, C. J., & Little, C. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7657 · Cited by 324
Vincent, K. A., Shyu, K.-G., Luo, Y., Magner, M., Tio, R. A., Jiang, C., Goldberg, M. A., Akita, G. Y., Gregory, R. J., & Isner, J. M. (2000) · Circulation · doi:10.1161/01.cir.102.18.2255 · Cited by 317
Drevs, J., Hofmann, I., Hugenschmidt, H., Wittig, C., Madjar, H., Müller, M., Wood, J. M., Martiny‐Baron, G., Unger, C., & Marmé, D. (2000) · PubMed · Cited by 308
Siemeister, G., Weindel, K., Mohrs, K., Barleon, B., Martiny‐Baron, G., & Marmé, D. (1996) · PubMed · Cited by 308
Elson, D. A., Thurston, G., Huang, L. E., Ginzinger, D. G., McDonald, D. M., Johnson, R. S., & Arbeit, J. M. (2001) · Genes & Development · doi:10.1101/gad.914801 · Cited by 299
Über eine sehr seltene Erkrankung der Netzhaut: Klinische Beobachtungen
Hippel, E. (1904) · Albrecht von Græfe's Archiv für Ophthalmologie · doi:10.1007/bf01994821 · Cited by 293
Prolyl 4-hydroxylases and their protein disulfide isomerase subunit
Kivirikko, K. I., & Myllyharju, J. (1998) · Matrix Biology · doi:10.1016/s0945-053x(98)90009-9 · Cited by 285
Wykoff, C. C., Pugh, C. W., Maxwell, P. H., Harris, A. L., & Ratcliffe, P. J. (2000) · Oncogene · doi:10.1038/sj.onc.1204012 · Cited by 266
Zhuang, Z., Bertheau, P., Emmert-Buck, M. R., Liotta, L. A., Gnarra, J. R., Linehan, W. M., & Lubensky, I. A. (1995) · Europe PMC (PubMed Central) · Cited by 262
Iliopoulos, O., Ohh, M., & Kaelin, W. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11661 · Cited by 260
Self-citationFormation of the VHL–Elongin BC Tumor Suppressor Complex Is Mediated by the Chaperonin TRiC
Feldman, D. E., Thulasiraman, V., Ferreyra, R. G., & Frydman, J. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80233-6 · Cited by 238
The von Hippel–Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal
Pause, A., Lee, S., Lonergan, K. M., & Klausner, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.993 · Cited by 238
Whaley, J. M., Naglich, J. G., Gelbert, L. M., Hsia, Y. E., Lamiell, J. M., Green, J. S., Collins, D. L., Neumann, H. P. H., Laidlaw, J., & Li, F. P. (1994) · PubMed Central · Cited by 232
Schoenfeld, A., Davidowitz, E. J., & Burk, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8817 · Cited by 230
Haemangioblastoma of the central nervous system in von Hippel–Lindau disease
Richard, Campello, Taillandier, Parker, & Resche (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00337.x · Cited by 220
Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor
Sweeney, W. E., Chen, Y., Nakanishi, K., Frost, P., & Avner, E. D. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00829.x · Cited by 219
Kanno, H., Kondo, K., Ito, S., Yamamoto, I., Fujii, S., Torigoe, S., Sakai, N., Hosaka, M., Shuin, T., & Yao, M. (1994) · PubMed · Cited by 208
Koochekpour, S., Jeffers, M., Wang, P. H., Gong, C., Taylor, G. A., Roessler, L. M., Stearman, R., Vasselli, J. R., Stetler-Stevenson, W. G., Kaelin, W. G., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5902 · Cited by 201
Self-citationVortmeyer, A. O., Gnarra, J. R., Emmert-Buck, M. R., Katz, D., Linehan, W. M., Oldfield, E. H., & Zhuang, Z. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90075-7 · Cited by 189
Lubensky, I. A., Gnarra, J. R., Bertheau, P., Walther, M. M., Linehan, W. M., & Zhuang, Z. (1996) · PubMed Central · Cited by 187
de Paulsen, N., Brychzy, A., Fournier, M.-C., Klausner, R. D., Gnarra, J. R., Pause, A., & Lee, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1387 · Cited by 187
Okuda, H., Saitoh, K., Hirai, S.-I., Iwai, K., Takaki, Y., Baba, M., Minato, N., Ohno, S., & Shuin, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107880200 · Cited by 176
ZUR FRAGE DER ANGIOMATOSIS RETINæ UND IHRER HIRNKOMPLIKATIONEN
LINDAU, A. (1926) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.1926.tb07786.x · Cited by 175
Lee, S., Neumann, M., Stearman, R. S., Stauber, R. H., Pause, A., Pavlakis, G. N., & Klausner, R. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1486 · Cited by 173
Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor.
Knebelmann, B., Karumanchi, S. A., Cohen, H. T., & Sukhatme, V. P. (1998) · PubMed · Cited by 170
Pal, S., Claffey, K. P., Cohen, H. T., & Mukhopadhyay, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26277 · Cited by 162
Mydlo, J. H., Michaeli, J., Cordon‐Cardo, C., Goldenberg, A. S., Heston, W. D. W., & Fair, W. R. (1989) · PubMed · Cited by 158
Oxygen Sensing Gets a Second Wind
Bruick, R. K., & McKnight, S. L. (2002) · Science · doi:10.1126/science.1069825 · Cited by 157
Prewett, M. C., Rothman, M., Waksal, H. W., Feldman, M. A., Bander, N. H., & Hicklin, D. J. (1998) · PubMed · Cited by 157
Duan, D. R., Humphrey, J. S., Chen, D. Y., Weng, Y., Sukegawa, J., Lee, S., Gnarra, J. R., Linehan, W. M., & Klausner, R. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6459 · Cited by 154
Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma.
Morita, R., Saito, S., Ishikawa, J., Ogawa, O., Yoshida, O., Yamakawa, K., & Nakamura, Y. (1991) · PubMed · Cited by 149
Kishida, T., Stackhouse, T. M., Chen, F., Lerman, M. I., & Zbar, B. (1995) · PubMed · Cited by 148
VHL Gene Deletion and Enhanced VEGF Gene Expression Detected in the Stromal Cells of Retinal Angioma
Chan, C. C. (1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.5.625 · Cited by 146
Characterization and comparative analysis of the EGLN gene family
Taylor, M. S. (2001) · Gene · doi:10.1016/s0378-1119(01)00633-3 · Cited by 145
Pal, S., Claffey, K. P., Dvorak, H. F., & Mukhopadhyay, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27509 · Cited by 144
Sang, N., Fang, J., Srinivas, V., Leshchinsky, I., & Caro, J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.9.2984-2992.2002 · Cited by 143
Blankenship, C., Naglich, J. G., Whaley, J. M., Seizinger, B. R., & Kley, N. (1999) · Oncogene · doi:10.1038/sj.onc.1202473 · Cited by 138
Anticancer drug targets: approaching angiogenesis
Keshet, E., & Ben‐Sasson, S. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8849 · Cited by 135
Allelotype of renal cell carcinoma.
Morita, R., Ishikawa, J., Tsutsumi, M., Hikiji, K., Tsukada, Y., Kamidono, S., Maeda, S., & Nakamura, Y. (1991) · PubMed · Cited by 134
Nwogu, J. I., Geenen, D., Bean, M., Brenner, M. C., Huang, X., & Buttrick, P. M. (2001) · Circulation · doi:10.1161/hc4301.097193 · Cited by 131
Identification of Alternative Spliced Variants of Human Hypoxia-inducible Factor-1α
Gothié, E., Richard, D. E., Berra, E., Pagès, G., & Pouysségur, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.6922 · Cited by 129
Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL
Woodward, E. R., Eng, C., McMahon, R., Voutilainen, R., Affara, N. A., Ponder, B., & Maher, E. R. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.7.1051 · Cited by 129
Expression pattern of the von Hippel-Lindau protein in human tissues.
Los, M., Jansen, G. H., Kaelin, W. G., Lips, C. J. M., Blijham, G. H., & Voest, E. E. (1996) · PubMed · Cited by 125
Self-citationImmunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues
Corless, C. L., Kibel, A. S., Iliopoulos, O., & Kaelin, W. G. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90035-6 · Cited by 121
Self-citationFlamme, I., Krieg, M., & Plate, K. H. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65541-1 · Cited by 119
Foster, K., Crossey, P. A., Cairns, P., Jw, H., Richards, F., Jones, M. H., Bentley, E., Affara, N. A., Ma, F.-S., & Maher, E. R. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.44 · Cited by 111
Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene.
Chen, F., Kishida, T., Duh, F.-M. C., Renbaum, P., Orcutt, M. L., Schmidt, L. S., & Zbar, B. (1995) · PubMed · Cited by 108
Davidowitz, E. J., Schoenfeld, A. R., & Burk, R. D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.865-874.2001 · Cited by 106
Bender, B., Gutsche, M., Gläsker, S., Müller, B., Kirste, G. R., Eng, C., & Neumann, H. P. H. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7015 · Cited by 103
Okuda, H., Hirai, S.-I., Takaki, Y., Kamada, M., Baba, M., Sakai, N., Kishida, T., Kaneko, S., Yao, M., Ohno, S., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1347 · Cited by 100
Hansen, W. J., Ohh, M., Moslehi, J. J., Kondo, K., Kaelin, W. G., & Welch, W. J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1947-1960.2002 · Cited by 98
Self-citationPause, A., Peterson, B. S., Schaffar, G., Stearman, R. S., & Klausner, R. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9533 · Cited by 96
Yu, F., White, S. B., Zhao, Q., & Lee, F. S. (2001) · PubMed · Cited by 95
Grossniklaus, H. E., Thomas, J. W., Vignesavaran, N., & Jarrett, W. H. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)32024-x · Cited by 94
Lieubeau, B., Rak, J. W., Jothy, S., Iliopoulos, O., Kaelin, W. G., & Kerbel, R. S. (1998) · PubMed · Cited by 91
Self-citationComprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes.
Thrash-Bingham, C., Greenberg, R. E., Howard, S., Bruzel, A., Bremer, M., Goll, A., Salazar, H., Freed, J. J., & Tartof, K. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2854 · Cited by 91
Genotype–phenotype correlations in von hippel–lindau disease
Neumann, H. P. H., & Bender, B. (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00336.x · Cited by 89
Expression of Growth Factors and Growth Factor Receptors in Capillary Hemangioblastoma
Böhling, T., Hatva, E., Kujala, M., Claesson, L., Alitalo, K. K., & Haltia, M. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199605000-00004 · Cited by 89
Brauch, H. B., Hoeppner, W., Jähnig, H., Wöhl, T., Engelhardt, D., Spelsberg, F. W., & Ritter, M. M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4454 · Cited by 89
Protein tyrosine kinase inhibitors: new treatment modalities?
Fabbro, D., Parkinson, D., & Matter, A. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00179-0 · Cited by 89
Ciardiello, F., Caputo, R., Bianco, R., Damiano, V., Pomatico, G., Pepe, S., Bianco, A. R., Agrawal, S., Mendelsohn, J. M., & Tortora, G. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.14.1087 · Cited by 86
Expression of Vascular Endothelial Growth Factor in Capillary Hemangioblastoma
Morii, K., Tanaka, R., Washiyama, K., Kumanishi, T., & Kuwano, R. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1885 · Cited by 84
Esteban-Barragán, M. A., Ávila, P., Álvarez-Tejado, M., Gutiérrez, M. D. C., García-Pardo, A., Sánchez‐Madrid, F., & Landázuri, M. O. (2002) · PubMed · Cited by 83
Renal cysts in transgenic mice expressing transforming growth factor-alpha.
Da, L., Lindemann, G. W., Merlino, G. T., Barash, B. D., Calvet, J. P., & Gattone, V. H. (1994) · PubMed · Cited by 83
Putative Control of Angiogenesis in Hemangioblastomas by the von Hippel-Lindau Tumor Suppressor Gene
Stratmann, R., Krieg, M., HAAS, R., & Plate, K. H. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199711000-00009 · Cited by 81
Hofstra, R. M. W., Stelwagen, T., Stulp, R. P., Jong, D. D., Hulsbeek, M. M. F., Kamsteeg, E.-J., van den Berg, A., Landsvater, R. M., Vermey, A., Molenaar, W. M., et al. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768845 · Cited by 79
Gorospe, M., Egan, J. M., Zbar, B., Lerman, M. I., Geil, L., Kuzmin, I., & Holbrook, N. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1289 · Cited by 74
Bender, B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.12.4568 · Cited by 70
Role of Exon 2-encoded β-Domain of the von Hippel-Lindau Tumor Suppressor Protein
Bonicalzi, M.-E., Groulx, I., de Paulsen, N., & Lee, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008295200 · Cited by 68
Lager, D. J., Slagel, D. D., & Palechek, P. L. (1994) · PubMed · Cited by 68
浜田, 邦., Kohno, T., Kawanishi, M., Ohwada, S., & Yokota, J. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199807)22:3<232::aid-gcc9>3.0.co;2-x · Cited by 67
Kroll, S. L., Paulding, W. R., Schnell, P. O., Barton, M. C., Conaway, J. W., Conaway, R. C., & Czyzyk-Krzeska, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30109 · Cited by 64
Comparative Sequence Analysis of the VHL Tumor Suppressor Gene
Woodward, E. R., Buchberger, A., Clifford, S. C., Hurst, L. D., Affara, N. A., & Maher, E. R. (2000) · Genomics · doi:10.1006/geno.2000.6144 · Cited by 59
Bar, M., Friedman, E., Jakobovitz-Picard, O., Leibowitz, G., Lerer, I., Abeliovich, D., & Gross, D. J. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.3251150.x · Cited by 59
An Important von Hippel-Lindau Tumor Suppressor Domain Mediates Sp1-Binding and Self-Association
Cohen, H. T., Zhou, M., Welsh, A. M., Zarghamee, S., Scholz, H., Mukhopadhyay, D., Kishida, T., Zbar, B., Knebelmann, B., & Sukhatme, V. P. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1767 · Cited by 57
Reifenberger, G., REIFENBERGER, J., Bilzer, T., Wechsler, W., & Collins, V. P. (1995) · Europe PMC (PubMed Central) · Cited by 53
Brauch, H. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.12.4101 · Cited by 51
Richard, S., Croisille, L., Yvart, J., Casadeval, N., Eschwège, P., Aghakhani, N., David, P., Gaudric, A., Scigalla, P., & Hermine, O. (2002) · Blood · doi:10.1182/blood.v99.10.3851 · Cited by 48
Groulx, I., Bonicalzi, M.-E., & Lee, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8991 · Cited by 43
Schoenfeld, A. R., Davidowitz, E. J., & Burk, R. D. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010215)91:4<457::aid-ijc1072>3.0.co;2-p · Cited by 40
Zhuang, Z., Gnarra, J. R., Dudley, C. F., Zbar, B., Linehan, W. M., & Lubensky, I. A. (1996) · PubMed · Cited by 37
Ohlsson, G., M�ller, J., Skakkeb�k, N. E., & Schwartz, M. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)13:6<505::aid-humu16>3.0.co;2-0 · Cited by 28
Kenck, C., Bugert, P., Wilhelm, M., & Kovács, G. (1997) · Oncogene · doi:10.1038/sj.onc.1200915 · Cited by 27
Maher, E. R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-374984-0.01632-6 · Cited by 25
Shuin, T., Kondo, K., Ashida, S., Okuda, H., Yoshida, M., Kanno, H., & Yao, M. (1999) · KARGER eBooks · doi:10.1159/000059976 · Cited by 23
Bauer, A. L., Paulding, W. R., Striet, J. B., Schnell, P. O., & Czyzyk-Krzeska, M. (2002) · PubMed · Cited by 13
Research works printed but not linked: 5
- Collins, E. T. Intra-ocular growths (two cases, brother and sister, with peculiar vascular new growth, probably retinal, affecting both eyes). Trans. Ophthalmol. Soc. UK 14, 141–149 (1894).
- Clifford, S., Prowse, A., Affara, N., Buys, C. & Maher, E. Inactivation of the von Hippel–Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosom. Cancer 22, 200–209 (1998). · DOI · Paper page
- Gallou, C. et al. Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC. Hum. Mutat. 13, 464–475 (1999). · DOI
- Ivan, M. et al. Biochemical purification and pharmacological inhibition of a mammalian HIF prolyl hydroxylase. Proc. Natl Acad. Sci. USA (in the press).
- Aiello, L. et al. Rapid and durable recovery of visual function in a patient with von Hippel–Lindau syndrome and optic nerve head hemangioma following systemic treatment with the VEGF receptor inhibitor SU5416. Ophthalmology (in the press).
Cited by
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
“The transcriptional activity of Hif-1 is thus repressed during normoxia (11).”
BackgroundInfluentialSuccinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108
“Since pVHL binding to the ODD domain is dependent on PHD activity (Kaelin, 2002; Safran and Kaelin, 2003), these results indicate that inhibiting SDH activity in cells results in decreased PHD activity. purified HA-pVHL protein and GFP-ODD/HA-pVHL complexes were detected by an anti-HA antibody…”
BackgroundReductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791
Lonser, R. R., Glenn, G. M., Walther, M., Chew, E. Y., Libutti, S. K., Linehan, W. M., & Oldfield, E. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13643-4 · Cited by 1,600
Metadata
- Authors
- Kaelin, W. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Kaelin, William G.
- ORCID
- Kaelin, William G.
- Venue
- Nature Reviews Cancer
- Published
- 2002-09
- Volume
- 2
- Issue
- 9
- Pages
- 673-682
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2093776019
- Semantic Scholar
- 6b13bcf0623256d5dceb071144a84d45b84f9a99
- Cited by
- 865
- References
- 146
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 25 · 2023: 21 · 2022: 24 · 2021: 25 · 2020: 34 · 2019: 32 · 2018: 28 · 2017: 22 · 2016: 27 · 2015: 29 · 2014: 39 · 2013: 42 · 2012: 46
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Keywords
- von Hippel-Lindau disease, VHL gene, hereditary cancer, oxygen sensing, prolyl hydroxylation, hypoxia signaling, tumour suppressor, cancer therapy
- MeSH terms
- Animals, von Hippel-Lindau Disease, Humans, Ligases, Neoplasms, Gene Expression Regulation, Neoplastic, Genetic Predisposition to Disease, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.